DFW Capital Partners
Founded in 1983, DFW focuses on making control investments in lower middle market companies with revenue of $20 million to $100 million and EBITDA of $3 million to $10 million. Based in Teaneck, N.J., the firm invests in healthcare and a few other sectors. Companies in its portfolio include Children’s Dental Health Associates, a dental service organization providing management and support to pediatric dentists; Evolution Research Group, a provider of clinical research site services for special patient populations; and Saol Therapeutics, a specialty pharmaceutical company focused on rare diseases.
